1 / 8

240521_Proliferative Diabetic Retinopathy (PDR) Global Market Report 2024

The proliferative diabetic retinopathy (pdr) market<br>size has grown rapidly in recent years. It will grow<br>from $2.16 billion in 2023 to $2.42 billion in 2024 at<br>a compound annual growth rate (CAGR) of 11.7%.<br>The proliferative diabetic retinopathy (pdr) market<br>size is expected to see rapid growth in the next few<br>years. It will grow to $3.62 billion in 2028 at a<br>compound annual growth rate (CAGR) of 10.6%.

TBRCMadhura0
Download Presentation

240521_Proliferative Diabetic Retinopathy (PDR) Global Market Report 2024

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Proliferative Diabetic Retinopathy (PDR) Global Market Report 2024 Global Forecast 2024 – 2033 Market Size, Drivers, And Trends Top Market Research Firm 2023! We are honored to be listed as a top company at the forefront of research, by the Business Management Review © The Business Research Company. All Rights Reserved.

  2. Proliferative Diabetic Retinopathy (PDR) Market Segments The Business Research Company segments the proliferative diabetic retinopathy (pdr) market report as: Anti-VEGF (Vascular Endothelial Growth Factor) Therapy, Intraocular Steroids, Laser Surgery, Vitrectomy By Source By Technology By Form By Administration Injectables, Oral, Other Mode Of Administrations By Application By Application Hospitals, Clinics, Other Applications . . . © The Business Research Company. All Rights Reserved.

  3. Market Statistics The proliferative diabetic retinopathy (pdr) market size has grown rapidly in recent years. It will grow from $2.16 billion in 2023 to $2.42 billion in 2024 at a compound annual growth rate (CAGR) of 11.7%. The proliferative diabetic retinopathy (pdr) market size is expected to see rapid growth in the next few years. It will grow to $3.62 billion in 2028 at a compound annual growth rate (CAGR) of 10.6%. $3.62 b B $2.42 B $2.16 B Click Here To Get A Sample Report © The Business Research Company. All Rights Reserved.

  4. Key Market Drivers And Trends Drivers The rising prevalence of diabetes is expected to propel the growth of the proliferative diabetic retinopathy (PDR) market going forward. Trends Major companies operating in the proliferative diabetic retinopathy market continuously focus on developing novel therapies to enhance treatment effectiveness, reduce treatment burden and improve patient outcomes. eneration (wet AMD) and choroidal neovascularization. Region North America was the largest region in the proliferative diabetic retinopathy market in 2023. Asia Pacific is expected to be the fastest- growing region in the forecast period. The regions covered in proliferative diabetic retinopathy (PDR) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. © The Business Research Company. All Rights Reserved.

  5. Top Players In The Market Major players in the proliferative diabetic retinopathy (pdr) market are Pfizer Inc., Johnson and Johnson Limited, F. Hoffmann-La Roche Ltd., Merck and Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, GSK PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Boehringer Ingelheim International GmbH, Merck KGaA, Kubota Vision Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Mylan N.V., Santen Pharmaceutical Co. Ltd., Lupin Limited, Genentech Inc., Sirnaomics Inc. Get More Information On The Market Report © The Business Research Company. All Rights Reserved.

  6. 7 Reasons Why TBRC Is The Solution You Need 1. Global Macroeconomic Impact: Assess global economic factors' influence on market growth. 2. Market Size Ratios: Explore market size, GDP proportions, and expenditure per capita. 3. Global Perspective: Reports cover 60 geographies for a comprehensive global understanding. 4. Localized Strategies: Create region-specific strategies aligning with market nuances. 5. Investment Insights: Identify growth segments through forecast data and market insights. 6. Competitor Benchmarking: Compare performance against key competitors. 7. Presentation Support: Reports offer reliable data for internal and external presentations. © The Business Research Company. All Rights Reserved.

  7. Americas The Business Research Company, 1295 N Providence Rd, Oxygen, PA 19063, USA ✆ +1 3156230293 Get In Touch Europe The Business Research Company 47 Anchorage Point, 42 Cuba Street, Canary Wharf, London, England, E14 8NE How ever you want to grow and expand, The Business Research Company can help as we provide research consulting solutions for businesses, government agencies consultancies, and market research companies. ✆ +44 207 1930 708 Asia The Business Research Company, 1st Floor, Anshu Colors Building, Road Number 1, Park View Enclave, Jubilee Hills, Hyderabad (India), 500033 info@tbrc.info ✆ +91 8897263534 @The Business Research Company. All rights reserved. © The Business Research Company. All Rights Reserved.

  8. Your Growth Insights Partner © The Business Research Company. All Rights Reserved.

More Related